{
  "meta": {
    "disclaimer": "Do not rely on openFDA to make decisions regarding medical care. While we make every effort to ensure that data is accurate, you should assume all results are unvalidated. We may limit or otherwise restrict your access to the API in line with our Terms of Service.",
    "terms": "https://open.fda.gov/terms/",
    "license": "https://open.fda.gov/license/",
    "last_updated": "2026-03-18",
    "results": {
      "skip": 0,
      "limit": 1,
      "total": 1
    }
  },
  "results": [
    {
      "status": "Terminated",
      "city": "Hauppauge",
      "state": "NY",
      "country": "United States",
      "classification": "Class II",
      "openfda": {},
      "product_type": "Drugs",
      "event_id": "81458",
      "recalling_firm": "Sciegen Pharmaceuticals Inc",
      "address_1": "89 Arkay Dr",
      "address_2": "N/A",
      "postal_code": "11788-3727",
      "voluntary_mandated": "Voluntary: Firm initiated",
      "initial_firm_notification": "Press Release",
      "distribution_pattern": "Nationwide",
      "recall_number": "D-0269-2019",
      "product_description": "Westminister Irbesartan Tablets, USP, 300mg, Rx Only,(a) 30-count bottle (NDC 69367-121-01, (b) 90-count bottle (NDC 69367-121-03), Manufactured by ScieGen Pharmaceuticals Inc. Hauppauge, NY 11755.  Manufactured for Westminster Pharmaceuticals LLC Olive Branch, MS 20854 Made in the USA.",
      "product_quantity": "5,989 HDPE",
      "reason_for_recall": "CGMP Deviations: FDA laboratory testing confirmed presence of an impurity, N-nitrosodimethylamine (NDEA) in product.",
      "recall_initiation_date": "20181029",
      "center_classification_date": "20181120",
      "termination_date": "20230925",
      "report_date": "20181128",
      "code_info": "69367-121-01 Irbesartan 300mg Tablets, 30 count bottle B162008A Sep-19   C162002A Feb-20   69367-121-03 Irbesartan 300mg Tablets, 90 count bottle B162008B Sep-19   C162002B Feb-20",
      "more_code_info": ""
    }
  ]
}